Investigating harmful ingredients in electronic cigarettes
Electronic Cigarettes: Emerging Ingredients, Acids, Toxicants, and Indicators of Non-Tobacco Nicotine
This study is looking at the ingredients in e-cigarettes to find out if any of them could be harmful to your health, so everyone can make safer choices about vaping.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project ID | NIH-10884691 on NIH RePORTER |
What this research studies
This research focuses on the changing chemistry of e-liquids used in electronic cigarettes, particularly the emerging ingredients that may pose health risks. The study will analyze 600 commercial e-cigarette products to identify harmful flavor chemicals and nicotine forms. By understanding the toxicological implications of these ingredients, the research aims to inform better regulation and public health strategies. Patients and the general public will benefit from insights into the safety of e-cigarette products.
Who could benefit from this research
Good fit: Ideal candidates for this research include current e-cigarette users, particularly teenagers and young adults who may be exposed to these harmful ingredients.
Not a fit: Patients who do not use e-cigarettes or are not affected by the toxicants in e-liquids may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved safety regulations for e-cigarettes, reducing health risks for users.
How similar studies have performed: Previous research has shown that analyzing the chemical composition of e-liquids can reveal significant health risks, indicating that this approach has potential for impactful findings.
Where this research is happening
Riverside, United States
- University of California Riverside — Riverside, United States (Active)
Researchers
- Principal investigator: Talbot, Prudence — University of California Riverside
- Study coordinator: Talbot, Prudence
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.